Amalia Resvani

The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives

George Agelis, Amalia Resvani, Serdar Durdağı et al. · European Journal of Medicinal Chemistry · 2012 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Rational design, efficient syntheses and biological evaluation of N , N ′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers

George Agelis, Amalia Resvani, Catherine Koukoulitsa et al. · European Journal of Medicinal Chemistry · 2013 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies

George Agelis, Panagiota Roumelioti, Amalia Resvani et al. · Journal of Computer-Aided Molecular Design · 2010 · 21 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation

George Agelis, Amalia Resvani, Minos–Timotheos Matsoukas et al. · Amino Acids · 2010 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matrices

G. Agelis, Amalia Resvani, Dimitrios Ntountaniotis et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2013 · 11 citations · Full text

Natural Sciences, Medicinal Chemistry, Pharmacology +14